Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
PHAR is expected to report earnings to fall 308.33% to -12 cents per share on November 06
Q3'25
Est.
$-0.12
Q2'25
Beat
by $0.07
Q1'25
Missed
by $0.21
Q4'24
Beat
by $0.07
Q3'24
Missed
by $0.02
The last earnings report on July 31 showed earnings per share of 5 cents, beating the estimate of -1 cents. With 3.00K shares outstanding, the current market capitalization sits at 778.38M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PHAR showed earnings on July 31, 2025. You can read more about the earnings report here.